2 options
The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Science and Technology (2007-2011). Subcommittee on Technology and Innovation
- Language:
- English
- Subjects (All):
- Biologicals--Effectiveness--Measurement--Standards--United States.
- Biologicals.
- Drugs--Effectiveness--Measurement--Standards--United States.
- Drugs.
- United States.
- Genre:
- Legislative hearings
- Legislative hearings.
- Physical Description:
- 1 online resource (iv, 112 pages) : illustrations
- Place of Publication:
- Washington : U.S. G.P.O., 2009.
- Contents:
- Q5E comparability of biotechnological/biological products subject to changes in their manufacturing process
- Comparability of medicinal products containing biotechnology-derived proteins as active substance quality issues
- FDA guidance concerning demonstration of comparability of human biological products, including therapeutic biotechnology-derived products.
- Notes:
- Title from title screen (viewed on Mar. 17, 2010).
- Paper version available for sale by the Supt. of Docs., U.S.G.P.O.
- Includes bibliographical references.
- "Serial no. 111-53."
- Electronic reproduction. [Place of publication not identified]: HathiTrust Digital Library. 2024.
- Other Format:
- Print version: United States. Congress. House. Committee on Science and Technology (2007-2011). Subcommittee on Technology and Innovation. Potential need for measurement standards to facilitate the research and development of biologic drugs.
- Microfiche: United States. Congress. House. Committee on Science and Technology (2007-2011). Subcommittee on Technology and Innovation. Potential need for measurement standards to facilitate the research and development of biologic drugs.
- OCLC:
- 557601871
- Access Restriction:
- Use copy Restrictions unspecified
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.